Literature DB >> 24448503

Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis.

Robert K McCall1, James G Ravenel, Paul J Nietert, Aleksandra Granath, Richard M Silver.   

Abstract

OBJECTIVE: This study aimed to determine the relationship between main pulmonary artery diameter (MPAD) and pulmonary hypertension (PH) in scleroderma patients with and without interstitial lung disease.
METHODS: We retrospectively reviewed 48 subjects with scleroderma who underwent a chest computed tomography (CT) and right heart catheterization with 6 months of each other. Patients were divided into 2 groups based on the absence or presence of interstitial lung disease on chest CT. Subset analysis was performed based on available pulmonary function tests and divided into groups by forced vital capacity (FVC). Computed tomographic scans were scored for extent of fibrosis and ground glass opacity. Pulmonary artery and ascending aorta measurements were obtained by 2 independent observers. Univariate and multivariate models were used to evaluate the correlation between MPAD and mean pulmonary artery pressure (mPAP) measured by right heart catheterization. Receiver operating characteristic analysis was performed for diagnostic accuracy of the MPAD measurement in predicting PH.
RESULTS: Strong correlations between mPAP and MPAD were found in this study regardless of the presence or absence of mild to moderate interstitial fibrosis on chest CT. When dividing patients based on FVC, the correlation between mPAP and MPAD was substantially attenuated. An MPAD value of 30.8 mm yielded the highest sensitivity and specificity at 81.3% and 87.5%, respectively.
CONCLUSIONS: In scleroderma patients, an enlarged main pulmonary artery (>30 mm) predicts PH even in the presence of mild to moderate fibrosis although the relationship may be attenuated in the presence of a low % FVC.

Entities:  

Mesh:

Year:  2014        PMID: 24448503      PMCID: PMC3959588          DOI: 10.1097/RCT.0b013e3182aa7fc5

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  20 in total

1.  Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program.

Authors:  J B Haimovici; B Trotman-Dickenson; E F Halpern; G W Dec; L C Ginns; J A Shepard; T C McLoud
Journal:  Acad Radiol       Date:  1997-05       Impact factor: 3.173

2.  Idiopathic pulmonary fibrosis: predicting response to therapy and survival.

Authors:  S E Gay; E A Kazerooni; G B Toews; J P Lynch; B H Gross; P N Cascade; D L Spizarny; A Flint; M A Schork; R I Whyte; J Popovich; R Hyzy; F J Martinez
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

3.  Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group.

Authors:  R T Tan; R Kuzo; L R Goodman; R Siegel; G B Haasler; K W Presberg
Journal:  Chest       Date:  1998-05       Impact factor: 9.410

4.  A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter.

Authors:  C S Ng; A U Wells; S P Padley
Journal:  J Thorac Imaging       Date:  1999-10       Impact factor: 3.000

5.  Pulmonary hypertension in patients with chronic pulmonary thromboembolism: chest radiograph and CT evaluation before and after surgery.

Authors:  H C Schmidt; H U Kauczor; H H Schild; C Renner; E Kirchhoff; P Lang; S Iversen; M Thelen
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  CT-determined pulmonary artery diameters in predicting pulmonary hypertension.

Authors:  K Kuriyama; G Gamsu; R G Stern; C E Cann; R J Herfkens; B H Brundage
Journal:  Invest Radiol       Date:  1984 Jan-Feb       Impact factor: 6.016

8.  The relationship between pulmonary artery pressure and pulmonary artery diameter in pulmonary hypertension.

Authors:  N R Moore; J P Scott; C D Flower; T W Higenbottam
Journal:  Clin Radiol       Date:  1988-09       Impact factor: 2.350

9.  CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.

Authors:  Sujal R Desai; Srihari Veeraraghavan; David M Hansell; Ageliki Nikolakopolou; Nicole S L Goh; Andrew G Nicholson; Thomas V Colby; Christopher P Denton; Carol M Black; Roland M du Bois; Athol U Wells
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

10.  Interstitial lung disease in systemic sclerosis.

Authors:  G C Ooi; M Y Mok; K W T Tsang; Y Wong; P L Khong; P C W Fung; S Chan; H F Tse; R W S Wong; W K Lam; C S Lau
Journal:  Acta Radiol       Date:  2003-05       Impact factor: 1.701

View more
  11 in total

Review 1.  Significance of main pulmonary artery dilation on imaging studies.

Authors:  Timothy E Raymond; Joseph E Khabbaza; Ruchi Yadav; Adriano R Tonelli
Journal:  Ann Am Thorac Soc       Date:  2014-12

2.  Pulmonary artery dilatation and obstructive sleep apnea.

Authors:  Joseph Simonson; Harley Greenberg; Arunabh Talwar
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

3.  Diameter of the dilated main pulmonary artery in patients with pulmonary hypertension decreases after lung transplantation.

Authors:  Hidenao Kayawake; Akihiro Aoyama; Hideyuki Kinoshita; Tomoya Yoneda; Shiro Baba; Yuki Teramoto; Aya Miyagawa-Hayashino; Kazuhiro Yamazaki; Hideki Motoyama; Masatsugu Hamaji; Daisuke Nakajima; Toyofumi F Chen-Yoshikawa; Hiroshi Date
Journal:  Surg Today       Date:  2019-10-08       Impact factor: 2.549

4.  Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.

Authors:  James Benjamin Gleason; Krunal B Patel; Felix Hernandez; Anas Hadeh; Kristin B Highland; Franck Rahaghi; Jinesh P Mehta
Journal:  Lung       Date:  2017-04-29       Impact factor: 2.584

5.  Lung volume determination by dual-source computed tomography in infants with pulmonary artery sling: a case-control study.

Authors:  Qiuyi Cai; Bing Wen; Jianlin Li; Liangbo Hu; Jian Liu; Hao Yang
Journal:  Transl Pediatr       Date:  2022-04

6.  Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Laith Alkukhun; Xiao-Feng Wang; Mostafa K Ahmed; Manfred Baumgartner; Marie M Budev; Raed A Dweik; Adriano R Tonelli
Journal:  Respir Med       Date:  2016-06-02       Impact factor: 3.415

7.  Risk factors for haemoptysis after percutaneous transthoracic needle biopsies in 4,172 cases: Focusing on the effects of enlarged main pulmonary artery diameter.

Authors:  Eui Jin Hwang; Chang Min Park; Soon Ho Yoon; Hyun-Ju Lim; Jin Mo Goo
Journal:  Eur Radiol       Date:  2017-10-23       Impact factor: 5.315

Review 8.  Update on scleroderma-associated interstitial lung disease.

Authors:  Ming-Hui Fan; Carol A Feghali-Bostwick; Richard M Silver
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

9.  Association between cardiovascular risk factors and the diameter of the main pulmonary artery in asymptomatic population in the Appalachian region.

Authors:  Timir K Paul; Ali E Alamin; Pooja Subedi; Michael Zhang; Mohamed M Diab; Arsham Alamian; Liang Wang; Gerald Blackwell; Hadii M Mamudu
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 10.  CT-base pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review.

Authors:  Yongchun Shen; Chun Wan; Panwen Tian; Yanqiu Wu; Xiaoou Li; Ting Yang; Jing An; Tao Wang; Lei Chen; Fuqiang Wen
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.